Idiopathic Thrombocytopenic Purpura
4R+3Dex Regimen May Lead to Durable Complete Response in Pediatric Chronic ITP
November 29, 2017Young patients with chronic ITP may experience relapse within 5 years of completing therapy. In this study, investigators sought to determine if the 4R+3Dex regimen for chronic ITP would improve response rates in pediatric patients with the disease.
Rituximab vs Splenectomy: Response Similar in Immune Thrombocytopenic Purpura
September 21, 2017Results of a retrospective single-center study showed that response to rituximab vs splenectomy as second-line therapy for steroid-refractory ITP was not significantly different between the 2 treatments.
Rare Case of Langerhans Cell Histiocytosis With Prior ITP Highlights Diagnostic Challenge for Clinicians
July 24, 2017A rare case of Langerhans cell histiocytosis (LCH) in a patient with idiopathic thrombocytopenic purpura (ITP) highlights the difficulty in diagnosing LCH.
Immune Thrombocytopenia (Fact Sheet)
June 19, 2017This fact sheet examines immune thrombocytopenia (ITP), including patient outlook, treatment, and ITP in pregnancy.
IL-11 Plus Glucocorticoids Safe, Effective for ITP in Adults
May 25, 2017Recent study results demonstrate that recombinant IL-11 with glucocorticoids is a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP) in adults.
Eradication of Infection Improves Outcomes for H Pylori+ patients with ITP
May 23, 2017Approximately 40% of ITP cases are caused by gram-negative H pylori infection; therefore, researchers sought to determine the effectiveness of infection eradication on platelet count in these patients.
Sign Up for Free e-newsletters
ONA Articles
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- Two Programs, One Goal: Meeting the Challenges of Oncology Navigation
- Navigating Patients with Hematologic Malignancies
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |